Table 1 Baseline characteristics of the patients
From: Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling
Training set | Test set | |
|---|---|---|
N | 573 | 190 |
Median follow-up | 145 months | 159 months |
% of Allo-HCT | 55 (9.6%) | 10 (5.3%) |
Relapses (%) | 129 (22.5%) | 43 (22.6%) |
Deaths (%) | 97 (16.9%) | 30 (15.8%) |
Median age (range) | 5 (0–19) | 5 (0–18) |
Sex (Male/Female) | 329 (57.4%)/244 (42.6%) | 103 (54.2%)/87 (45.8%) |
Down syndrome | 17 (2.97%) | 2 (1.05%) |
Standard Risk | 157 (27.4%) | 50 (26.3%) |
Intermediate Risk | 196 (34.2%) | 70 (36.8%) |
High Risk | 206 (35.9%) | 64 (33.7%) |
Infant | 15 (2.4%) | 5 (2.6%) |